Terms: = Germ cell tumor AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT AND Treatment
4 results:
1. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
2. MN1 altered astroblastoma with APC and lrp1b gene mutations: a unique variant in the cervical spine of a pediatric patient.
Mugge L; Dang DD; Stabingas K; Keating G; Rossi C; Keating R
Childs Nerv Syst; 2023 May; 39(5):1309-1315. PubMed ID: 36648513
[TBL] [Abstract] [Full Text] [Related]
3. PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.
Dong Y; Zhao L; Duan J; Bai H; Chen D; Li S; Yu Y; Xiao M; Zhang Q; Duan Q; Sun T; Qi C; Wang J; Wang Z
Cell Prolif; 2022 Sep; 55(9):e13283. PubMed ID: 35811392
[TBL] [Abstract] [Full Text] [Related]
4. Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.
Luo L; Lin L; Zhang X; Cai Q; Zhao H; Xu C; Cong Q
Biomed Res Int; 2020; 2020():1314967. PubMed ID: 31998776
[TBL] [Abstract] [Full Text] [Related]
